302 results on '"Greer, Tracy L."'
Search Results
2. Neural substrates of emotional conflict with anxiety in major depressive disorder: Findings from the Establishing Moderators and biosignatures of Antidepressant Response in Clinical Care (EMBARC) randomized controlled trial
3. Moderators of treatment response to exercise in participants with stimulant use disorder: Exploratory results from the Stimulant Reduction using Dosed Exercise (STRIDE)CTN-0037 study
4. Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder
5. Identifying and responding to trial implementation challenges during multisite clinical trials
6. Comprehensive phenotyping of depression disease trajectory and risk: Rationale and design of Texas Resilience Against Depression study (T-RAD)
7. Dysfunctional adaptive immune response in adolescents and young adults with suicide behavior
8. Acute and long-term cannabis use among stimulant users: Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial
9. Sex differences in the association of baseline c-reactive protein (CRP) and acute-phase treatment outcomes in major depressive disorder: Findings from the EMBARC study
10. Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial
11. List of Contributors
12. Pharmacological and Nonpharmacological Treatment Effects on Functional Outcomes in Major Depressive Disorder
13. Precision Medicine for the Treatment of Depression
14. Primer on Depression
15. A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorder
16. Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study
17. A complier average causal effect analysis of the Stimulant Reduction Intervention using dosed exercise study
18. A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project
19. Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection
20. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder
21. Stimulant Reduction Intervention using Dosed Exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial
22. Psychosocial relationship status and quality as predictors of exercise intervention adherence and substance use outcomes: Results from the STRIDE (CTN-0037) study
23. Cardiorespiratory fitness and body composition of stimulant users: A baseline analysis of the STRIDE cohort
24. Functional and Psychosocial Consequences of Major Depressive Disorder
25. Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial
26. Evaluation of anhedonia with the Snaith–Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder
27. Dose-dependent changes in cognitive function with exercise augmentation for major depression: Results from the TREAD study
28. Self-rated measure of pain frequency, intensity, and burden: Psychometric properties of a new instrument for the assessment of pain
29. A health education intervention as the control condition in the CTN-0037 STRIDE multi-site exercise trial: Rationale and description
30. Cognitive dysfunction in unipolar depression: Implications for treatment
31. The Promise of Exercise Interventions for the Anxiety Disorders
32. Prediction of treatment outcomes to exercise in patients with nonremitted major depressive disorder
33. Brief Mindfulness Video to Reduce Pelvic Exam-Related Anxiety and Pain [A89]
34. STimulant Reduction Intervention using Dosed Exercise (STRIDE) – Description of the exercise intervention and behavioral program to ensure adherence
35. Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse
36. A primary care first (PCP-first) model to screen and treat depression: A VitalSign6 report from a second cohort of 32,106 patients
37. Effects of serum Brain Derived Neurotrophic Factor on exercise augmentation treatment of depression
38. Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders
39. Implications of cognitive impairments on functional outcomes in major depressive disorder
40. Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry
41. DATE: Depressed adolescents treated with exercise: Study rationale and design for a pilot study
42. Circular RNAs as putative biomarkers for depression diagnosis and treatment
43. Depression
44. Defining and Measuring Functional: Recovery from Depression
45. Exercise in the treatment of depression
46. Reductions in Stress and Depressive Symptoms in Mothers of Substance-Exposed Infants, Participating in a Psychosocial Program
47. Pathology-Congruent Biases as Biomarkers for Psychopathology
48. The Promise of Biomarkers for Psychiatry
49. Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression
50. Association Between Depression Severity and Neurocognitive Function in Major Depressive Disorder: A Review and Synthesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.